Rapid risk assessment: Acute encephalitis associated with infection with Borna disease virus 1, Germany
Borna disease virus 1 (BoDV-1) has been associated with human disease in four cases in Germany resulting in the death of three people. As three of the cases belong to a cluster of solid organ recipients from a single donor, donor-derived BoDV-1 transmission is possible. There is no evidence that the donor had any clinical manifestation of the disease.
Rapid risk assessment: Autochthonous cases of chikungunya fever on the Caribbean island, Saint Martin
Following the confirmation of two cases of autochthonous chikungunya on the Caribbean island of St Martin, ECDC performed a rapid risk assessment.
Rapid risk assessment: Zika virus infection outbreak, French Polynesia
This document assesses the risk associated with the outbreak of Zika virus infections, considered as an emerging disease, to public health in the EU/EEA and the risk to EU/EEA citizens in order to anticipate future developments.
Risk of importation and spread of malaria and other vector-borne diseases associated with the arrival of migrants to the EU, 22 October 2015
This rapid risk assessment assesses the specific risk related to importation and spread of vector borne diseases in the context of a large number of migrants to the EU. It does not cover other health needs for these populations.
Rapid risk assessment: Crimean–Congo haemorrhagic fever in Spain, 9 September 2016
On 31 August 2016 the autonomous Community of Madrid, Spain, reported two cases of infection with Crimean–Congo haemorrhagic fever (CCHF) virus. This document assesses the risk associated with the occurrence of two cases of Crimean–Congo haemorrhagic fever in Spain.
Rapid risk assessment: Outbreak of Rift Valley fever in Niger, 10 October 2016
This rapid risk assessment monitors the threat posed by Rift Valley fever (RVF) which has been reported in regions of eastern and southern Africa, and in most of the sub-Saharan and West African countries.
Rapid risk assessment: Public health risks related to communicable diseases during the hajj 2019, Saudi Arabia, 9–14 August 2019
In 2019, the hajj will take place between 9 and 14 August. The risk for EU/EEA citizens to become infected with communicable diseases during the 2019 hajj is considered low, thanks to the vaccination requirements for travelling to Makkah (Mecca) and the Saudi Arabian preparedness plans that address the management of health hazards during and after hajj.
- Food- and waterborne diseases
- Hepatitis A
- Hepatitis B
- Mass gathering
- Meningococcal disease
- Middle East respiratory syndrome coronavirus
- Public health threat
- Saudi Arabia
- Travellers' health
- Vaccine preventable diseases
- Vector-borne disease